Report cover image

Global Musculoskeletal System Disorder Market Research Report 2024

Publisher QYResearch Group
Published Nov 01, 2024
Length 188 Pages
SKU # QYR19321092

Description

Global Musculoskeletal System Disorder Market Research Report 2024



The global Musculoskeletal System Disorder market was valued at US$ 147839 million in 2023 and is anticipated to reach US$ 195182 million by 2030, witnessing a CAGR of 4.19% during the forecast period 2024-2030.

North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of 3.89% during the forecast period of 2024 through 2030.

Asia-Pacific market for Musculoskeletal System Disorder is estimated to increase from $ 26000 million in 2023 to reach $ 35515 million by 2030, at a CAGR of 4.84 % during the forecast period of 2024 through 2030.

The major global companies of Musculoskeletal System Disorder include AbbVie, Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, Bristol-Myers Squibb, Medtronic, Arthrex, Haleon, etc. In 2023, the world's top five vendors accounted for approximately 31.46% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder.

The Musculoskeletal System Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Musculoskeletal System Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

AbbVie

Pfizer

Johnson & Johnson

Haleon

Bayer

Biogen

Novartis

Sanofi

Sarepta Therapeutics

Merck & Co

Nippon Shinyaku

Bristol-Myers Squibb

Roche

UCB

Stryker

Zimmer Biomet

Smith & Nephew

Globus Medical

Medtronic

B Braun

Acumed

Orthofix

Arthrex

MicroPort

WEGO

Segment by Type

Joint Disorder

Bone Disorder

Muscle Disorder

Other

Segment by Application

Hospital & Clinic

Retail Pharmacy

Other

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Middle East

Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Musculoskeletal System Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

188 Pages
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Joint Disorder
1.2.3 Bone Disorder
1.2.4 Muscle Disorder
1.3 Market by Application
1.3.1 Global Musculoskeletal System Disorder Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital & Clinic
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal System Disorder Market Perspective (2019-2030)
2.2 Global Musculoskeletal System Disorder Growth Trends by Region
2.2.1 Global Musculoskeletal System Disorder Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Musculoskeletal System Disorder Historic Market Size by Region (2019-2024)
2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030)
2.3 Musculoskeletal System Disorder Market Dynamics
2.3.1 Musculoskeletal System Disorder Industry Trends
2.3.2 Musculoskeletal System Disorder Market Drivers
2.3.3 Musculoskeletal System Disorder Market Challenges
2.3.4 Musculoskeletal System Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal System Disorder Players by Revenue
3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2019-2024)
3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Musculoskeletal System Disorder Market by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Musculoskeletal System Disorder Revenue
3.4 Global Musculoskeletal System Disorder Market Concentration Ratio
3.4.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2023
3.5 Global Key Players of Musculoskeletal System Disorder Head office and Area Served
3.6 Global Key Players of Musculoskeletal System Disorder, Product
3.7 Global Key Players of Musculoskeletal System Disorder, Founded Date
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal System Disorder Breakdown Data by Type
4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2019-2024)
4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2025-2030)
5 Musculoskeletal System Disorder Breakdown Data by Application
5.1 Global Musculoskeletal System Disorder Historic Market Size by Application (2019-2024)
5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Musculoskeletal System Disorder Market Size (2019-2030)
6.2 North America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Musculoskeletal System Disorder Market Size by Country (2019-2024)
6.4 North America Musculoskeletal System Disorder Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Musculoskeletal System Disorder Market Size (2019-2030)
7.2 Europe Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Musculoskeletal System Disorder Market Size by Country (2019-2024)
7.4 Europe Musculoskeletal System Disorder Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal System Disorder Market Size (2019-2030)
8.2 Asia-Pacific Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2019-2024)
8.4 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Musculoskeletal System Disorder Market Size (2019-2030)
9.2 Latin America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Musculoskeletal System Disorder Market Size by Country (2019-2024)
9.4 Latin America Musculoskeletal System Disorder Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal System Disorder Market Size (2019-2030)
10.2 Middle East & Africa Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2019-2024)
10.4 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2025-2030)
10.5 Middle East
10.6 Africa
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Musculoskeletal System Disorder Introduction
11.1.4 AbbVie Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Musculoskeletal System Disorder Introduction
11.2.4 Pfizer Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Musculoskeletal System Disorder Introduction
11.3.4 Johnson & Johnson Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Haleon
11.4.1 Haleon Company Details
11.4.2 Haleon Business Overview
11.4.3 Haleon Musculoskeletal System Disorder Introduction
11.4.4 Haleon Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.4.5 Haleon Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Musculoskeletal System Disorder Introduction
11.5.4 Bayer Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Musculoskeletal System Disorder Introduction
11.6.4 Biogen Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.6.5 Biogen Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Musculoskeletal System Disorder Introduction
11.7.4 Novartis Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Musculoskeletal System Disorder Introduction
11.8.4 Sanofi Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.9 Sarepta Therapeutics
11.9.1 Sarepta Therapeutics Company Details
11.9.2 Sarepta Therapeutics Business Overview
11.9.3 Sarepta Therapeutics Musculoskeletal System Disorder Introduction
11.9.4 Sarepta Therapeutics Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.9.5 Sarepta Therapeutics Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Details
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Musculoskeletal System Disorder Introduction
11.10.4 Merck & Co Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.11 Nippon Shinyaku
11.11.1 Nippon Shinyaku Company Details
11.11.2 Nippon Shinyaku Business Overview
11.11.3 Nippon Shinyaku Musculoskeletal System Disorder Introduction
11.11.4 Nippon Shinyaku Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.11.5 Nippon Shinyaku Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Musculoskeletal System Disorder Introduction
11.12.4 Bristol-Myers Squibb Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Musculoskeletal System Disorder Introduction
11.13.4 Roche Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.13.5 Roche Recent Development
11.14 UCB
11.14.1 UCB Company Details
11.14.2 UCB Business Overview
11.14.3 UCB Musculoskeletal System Disorder Introduction
11.14.4 UCB Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.15 Stryker
11.15.1 Stryker Company Details
11.15.2 Stryker Business Overview
11.15.3 Stryker Musculoskeletal System Disorder Introduction
11.15.4 Stryker Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.15.5 Stryker Recent Development
11.16 Zimmer Biomet
11.16.1 Zimmer Biomet Company Details
11.16.2 Zimmer Biomet Business Overview
11.16.3 Zimmer Biomet Musculoskeletal System Disorder Introduction
11.16.4 Zimmer Biomet Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.16.5 Zimmer Biomet Recent Development
11.17 Smith & Nephew
11.17.1 Smith & Nephew Company Details
11.17.2 Smith & Nephew Business Overview
11.17.3 Smith & Nephew Musculoskeletal System Disorder Introduction
11.17.4 Smith & Nephew Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.18 Globus Medical
11.18.1 Globus Medical Company Details
11.18.2 Globus Medical Business Overview
11.18.3 Globus Medical Musculoskeletal System Disorder Introduction
11.18.4 Globus Medical Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.18.5 Globus Medical Recent Development
11.19 Medtronic
11.19.1 Medtronic Company Details
11.19.2 Medtronic Business Overview
11.19.3 Medtronic Musculoskeletal System Disorder Introduction
11.19.4 Medtronic Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.19.5 Medtronic Recent Development
11.20 B Braun
11.20.1 B Braun Company Details
11.20.2 B Braun Business Overview
11.20.3 B Braun Musculoskeletal System Disorder Introduction
11.20.4 B Braun Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.20.5 B Braun Recent Development
11.21 Acumed
11.21.1 Acumed Company Details
11.21.2 Acumed Business Overview
11.21.3 Acumed Musculoskeletal System Disorder Introduction
11.21.4 Acumed Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.21.5 Acumed Recent Development
11.22 Orthofix
11.22.1 Orthofix Company Details
11.22.2 Orthofix Business Overview
11.22.3 Orthofix Musculoskeletal System Disorder Introduction
11.22.4 Orthofix Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.22.5 Orthofix Recent Development
11.23 Arthrex
11.23.1 Arthrex Company Details
11.23.2 Arthrex Business Overview
11.23.3 Arthrex Musculoskeletal System Disorder Introduction
11.23.4 Arthrex Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.24 MicroPort
11.24.1 MicroPort Company Details
11.24.2 MicroPort Business Overview
11.24.3 MicroPort Musculoskeletal System Disorder Introduction
11.24.4 MicroPort Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.25 WEGO
11.25.1 WEGO Company Details
11.25.2 WEGO Business Overview
11.25.3 WEGO Musculoskeletal System Disorder Introduction
11.25.4 WEGO Revenue in Musculoskeletal System Disorder Business (2019-2024)
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Musculoskeletal System Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Global Musculoskeletal System Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 3. Global Musculoskeletal System Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 4. Global Musculoskeletal System Disorder Market Size by Region (2019-2024) & (US$ Million)
Table 5. Global Musculoskeletal System Disorder Market Share by Region (2019-2024)
Table 6. Global Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 7. Global Musculoskeletal System Disorder Market Share by Region (2025-2030)
Table 8. Musculoskeletal System Disorder Market Trends
Table 9. Musculoskeletal System Disorder Market Drivers
Table 10. Musculoskeletal System Disorder Market Challenges
Table 11. Musculoskeletal System Disorder Market Restraints
Table 12. Global Musculoskeletal System Disorder Revenue by Players (2019-2024) & (US$ Million)
Table 13. Global Musculoskeletal System Disorder Market Share by Players (2019-2024)
Table 14. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal System Disorder as of 2023)
Table 15. Ranking of Global Top Musculoskeletal System Disorder Companies by Revenue (US$ Million) in 2023
Table 16. Global 5 Largest Players Market Share by Musculoskeletal System Disorder Revenue (CR5 and HHI) & (2019-2024)
Table 17. Global Key Players of Musculoskeletal System Disorder, Headquarters and Area Served
Table 18. Global Key Players of Musculoskeletal System Disorder, Product and Application
Table 19. Global Key Players of Musculoskeletal System Disorder, Founded Date
Table 20. Mergers & Acquisitions, Expansion Plans

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us